Breaking Buc-ee’s Files Lawsuit Over Beaver Logo in Ohio; Sparks Public Reaction Tourists Embrace Sunhats at Athens’ Ancient Sites Amidst Record Crowds and Heat President Trump to Lead Pre-Race Lap at IndyCar Freedom 250 in Washington D.C. Health Officials Caution Against Unproven Glutathione Use for Wildland Firefighters JJ Bleday Completes Historic Cycle for Cincinnati Reds

Sunday August 23, 2026

Reporter

Creative Medical Technology Holdings, Inc.

2Articles Published

4Communities Covered

Published Articles

Press Release

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning

Aug 20

Press Release

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms

Aug 6